Telomere Length in Haemopoietic Stem Cells can be Determined from that of Mononuclear Blood Cells or Whole Blood
- 1 January 2002
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 43 (10) , 2017-2020
- https://doi.org/10.1080/1042819021000015970
Abstract
Telomere length can be used to predict the replicative capacity of haematological progenitor cells and may be an important prognostic factor for the onset of cellular immune dysfunction. However, such measurements require invasive bone marrow (BM) biopsies and laborious stem cell isolations that are impractical in a clinical setting. Previous studies have used peripheral blood (PB) cells as an indicator of stem cell telomere length without demonstrating a correlation. In this study, we examined the telomere length in PB, isolated mononuclear cells (MNC) and BM aspirates from each of 19 patients ranging in age from 45 to 81 years. Correlation analysis confirmed that mean telomere length of BM aspirates was equivalent to that of PB ( r =0.85, P <0.001), or MNC ( r =0.94, P <0.001). Since BM is a heterogeneous population of cells, we have also shown in 13 separate patients that the mean telomere length in isolated peripheral blood stem cell (PBSC) harvests was equivalent to that of isolated CD34 + stem cells ( r =0.83, P <0.001). Thus, telomere length in haemopoietic stem cells can be determined from that of whole or fractionated PB in future studies of haematological disorders.Keywords
This publication has 13 references indexed in Scilit:
- Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phaseBlood, 2000
- Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantationBlood, 2000
- Accelerated replicative senescence of the peripheral immune system induced by HIV infectionAIDS, 2000
- Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization processOncogene, 1999
- Progressive Telomere Shortening in Aplastic AnemiaBlood, 1998
- Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplantsThe Lancet, 1998
- Accelerated telomere shortening in ataxia telangiectasiaNature Genetics, 1996
- Telomeres, Telomerase, and ImmortalityJNCI Journal of the National Cancer Institute, 1995
- Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.Proceedings of the National Academy of Sciences, 1994
- Telomere reduction in human colorectal carcinoma and with ageingNature, 1990